| Authors: |
Varghese J; Vancouver General Hosptial, University of British Columbia, Vancouver, Canada. Electronic address: julia.varghese@bccancer.bc.ca., Venner CP; BC Cancer, Vancouver Centre, Vancouver, Canada., Louzada M; London Regional Cancer Center, London, Ontario, Canada., Reece D; Princess Margaret Cancer Centre, Toronto, Canada; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., White D; Queen Elizabeth II Health Sciences Centre. Dalhousie University, Halifax, Nova Scotia, Canada., Sharma S; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Su J; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Chu MP; Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Jimenez-Zepeda VH; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., McCurdy A; The Ottawa Hospital, Ottawa, Ontario, Canada., Song K; Vancouver General Hosptial, University of British Columbia, Vancouver, Canada., Mian H; Juravinski Cancer Center, Hamilton, Ontario, Canada., Sebag M; McGill University, Montreal, Québec, Canada., Stakiw J; Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Reiman A; Saint John Regional Hospital, Saint John, New Brunswick, Canada., Kotb R; Cancer Care Manitoba, Winnipeg, Manitoba, Canada., Aslam M; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada., Kaedbey R; Jewish General Hospital, Montreal, Quebec., Bergstrom D; Division of Hematology, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, St John's, NL, Canada., Gul E; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., LeBlanc R; Hematology-Oncology and Cell Therapy University Institute, Maisonneuve-Rosemont Hospital Research Centre, Université de Montréal, Montreal, Quebec, Canada. |
